Correspondence santos.franco@ucdenver.edu (S.J.F.), umueller@scripps.edu (U.M.) In Brief Gil-Sanz et al. show how genetic background can affect transgene expression in genetically modified mice, thus potentially affecting the interpretation of genetic fate-mapping results that are carried out with such transgenic lines.
INTRODUCTION
We identified an RGC lineage in the neocortex that expresses the Cux2 gene and is fate restricted (Franco et al., 2012) . Using Cux2-Cre mice for cumulative lineage-tracing studies, we reported that 75% of all neurons in the Cux2-Cre lineage are found in upper neocortical cell layers and 25% in lower layers (Franco et al., 2012) . Most neurons of the Cux2-Cre lineage expressed Satb2 (Franco et al., 2012) , which is used as a marker for callosal projection neurons in upper and lower layers and for locally projecting neurons in layer 4 (Alcamo et al., 2008; Arlotta et al., 2005; Britanova et al., 2008) . We will refer to these neurons as corticocortical projection neurons. Some cells in the Cux2-Cre lineage expressed the interneuron marker Gad65/67 and few cells were positive for Ctip2 (Franco et al., 2012) , which is expressed in interneurons and in corticofugal projection neurons (Arlotta et al., 2005; Franco et al., 2012) . Similar observations were made when we used Cux2-CreERT2 mice and tamoxifen injections at E10.5 for temporal genetic fate-mapping (Franco et al., 2012) , indicating that progenitors expressing Cux2-CreERT2 at E10.5 are fate restricted.
Using similar strategies, Guo et al. (2013) found no evidence for fate-restricted RGCs. Here we have addressed this discrepancy and provide a likely explanation why Guo et al. reached a conclusion different from ours. We show that the recombination pattern in Cux2-Cre/CreERT2 mice depends on genetic background and breeding strategies. Specifically, repeated sibling interbreedings of mice carrying the transgene on the C57BL/6 genetic background lead to progressive changes in the expression pattern of transgenes from the Cux2 locus that no longer reflects endogenous Cux2 expression. Changes in the expression pattern of the transgene are also observed on different genetic backgrounds. Notably, Cux2-Cre/CreERT2 mice obtained by the Chen laboratory originally came from colonies that were maintained for over 10 generations (> 3 years) by interbreeding mice homozygous for the transgene, which we show here affects the Cre expression pattern. Analysis of the results presented in Eckler et al. (2015) in this issue of Neuron suggests that the Chen laboratory is working with a Cux2-CreERT2 subline with a recombination pattern that no longer recapitulates the expression pattern of the endogenous Cux2 locus. Importantly, by breeding mice with the aberrant transgene expression pattern onto different genetic backgrounds, the recombination pattern that recapitulates the expression pattern of the endogenous Cux2 genetic locus can be reestablished. Using these ''recovered'' mice as well as additional fate-mapping strategies, we provide further evidence supporting the conclusion that the neocortical VZ contains fate-restricted progenitors.
RESULTS
The Cux2 Genetic Locus Exhibits Variable Activity that Depends on Genetic Background and Is Active in the Developing Germline All animal procedures were performed using Institutional Animal Care and Use Committees (IACUC)-approved protocols that adhere to the standards of the NIH. Cux2-Cre and Cux2-CreERT2 mice were generated on a C57BL/6 background (Franco et al., 2012 (Franco et al., , 2011 Figure 1B ; ''Sparse'') that spanned all neocortical cell layers equally (Figures 1B and 1E) . This was in stark contrast to the expression pattern of the endogenous Cux2 genetic locus and the recombination pattern in Cux2-Cre mice that were not maintained by breeding homozygous littermates ( Figure 1A ) (Franco et al., 2012 Figure 1B ; ''Recovered''). We also observed that crossing inbred Cux2 Cre/Cre mice to the Rosa26-NZG reporter line on an FVB/NJ background resulted in a recombination pattern that was much broader than the original pattern ( Figure 1C ). This expanded pattern was seen in all brain regions, including the neocortex and hippocampus (Figure 1C) , and included all neocortical cell layers ( Figure 1F ). The original pattern was recovered when Cux2 Cre/Cre mice were outbred onto the FVB/NJ background for five generations (Figures 1D and 1F) . These data indicate that the recombination pattern in Cux2-Cre mice is subject to differences in genetic background of the parents carrying the Cre and/or Cre-reporter transgenes.
We also collaborated with The Jackson Laboratory and the Allen Institute for Brain Science to characterize Cux2-Cre and Cux2-CreERT2 mice for the Allen Brain Atlas (ABA) website (www.brain-map.org). Mice that were shipped to The Jackson Laboratory and Allen Institute had been maintained by homozygous inbreeding for three to four generations. Cux2-Cre mice maintained by homozygous breedings for a few generations exhibited layer-specific recombination throughout different functional domains of the neocortex (Figures S1A and S1C), although some brains showed a somewhat broadened expression pattern especially in the lateral cortex (not shown). This broadened expression was likely caused by genetic drift caused by inbreeding of the Cux2-Cre homozygous mice for a few generations. Surprisingly, some brains on the ABA website displayed uniform recombination throughout the whole brain, including all neocortical cell layers ( Figure S1D , not shown). Mice with this broad recombination pattern inherited Cux2-Cre and the Cre-reporter allele from the same parent (Figure S1B ; ''Breeding Strategy 2''). We hypothesized that Cux2-Cre is expressed in the developing F1 germline where it drives recombination of the reporter, thus leading to inheritance of the recombined reporter allele in F2 progeny ( Figure S1B ). Indeed, breeding Cux2-Cre;Ai9 double heterozygous mice to WT mice led to ubiquitous reporter gene expression throughout the entire animal in F2 progeny (Figures S1E and S1F) . This was true even in F2 animals that did not inherit Cux2-Cre (Figures S1E and S1F), indicating F1 germline recombination. Not all F2 embryos exhibited ubiquitous recombination (Figures S1D and S1E), indicating mosaic germline recombination. We confirmed that breeding Cux2-Cre;Rosa-NZG double heterozygous F1 mice to WT animals produced similar results, with some F2 embryos exhibiting ubiquitous recombination even in the absence of the Cre allele ( Figure S1G ). Future releases of the ABA website will include information to specify the breeding scheme and inheritance pattern of the Cux2-Cre and Crereporter alleles.
We conclude that the expression pattern of the Cre transgene in Cux2-Cre/CreERT2 mice is dependent on genetic background and breeding scheme.
Cux2-Cre Mice Mark a Subset of Neocortical Projection Neurons
To confirm our original lineage-mapping results (Franco et al., 2012) , we performed additional analyses using Cux2-Cre mice that were continuously maintained by breedings of heterozygous Cux2-Cre mice with C57BL/6 wild-type mice, a breeding scheme that maintains the same expression pattern for Cre as for the endogenous Cux2 gene as determined by in situ hybridization (Franco et al., 2012; Nieto et al., 2004; Zimmer et al., 2004) . We analyzed recombination in the mediolateral part of the neocortex along its rostrocaudal extent at embryonic days (E) 10.5, E12.5, and E14.5. As reported (Franco et al., 2012) , Cux2-Cre induced recombination in a subset of Pax6-positive RGCs that increased in numbers from E10.5 to E14.5 ( Figures S2A and S2B ). Cre protein was present in the recombined progenitors ( Figure S2C ). We then analyzed brains at postnatal day (P) 30 along the rostrocaudal extent of the brain. A Nex/Neurod6-Cre control transgene that induces recombination in nearly all neocortical projection neurons (Belvindrah et al., 2007a; Wu et al., 2005) labeled neurons equally in all cell layers ( Figure S2D ). Cux2-Cre mice exhibited recombination extensively in upper neocortical cell layers and much less in lower layers ( Figure S2D ). Some signal in lower layers is expected because Cux2-Cre-mediated recombination labels interneurons that reside in all cell layers and Satb2 + projection neurons that reside in upper and, to a lesser extent, lower layers (Franco et al., 2012) . In addition, the Ai9 reporter exhibited a diffuse signal in lower layers consistent with the fact that tdTomato is expressed in the processes of upper-layer projection neurons that arborize in lower layers. However, fluorescence in cell bodies was distinguished from that in the neuropil by confocal microscopy, which revealed no fluorescence in the majority of pyramidal neurons in lower layers ( Figure S2E ). These data are consistent with our earlier publication (Franco et al., 2012) and confirm that when genetic background is carefully controlled, Cux2-Cre mice are a useful tool to determine the full complement of cells that express Cre from the Cux2 locus at any point during their development and maturation. 
(legend continued on next page)
To define the subtype of neurons fate-mapped with the Cux2-Cre line, we analyzed Cux2-Cre;Rosa26R-LacZ for co-expression of bGal with Satb2, a marker for corticocortical projection neurons (Alcamo et al., 2008; Britanova et al., 2008) and with Ctip2 and Tle4, markers for subsets of corticofugal projection neurons (Arlotta et al., 2005; Koop et al., 1996) . b-gal protein in the Rosa26R-LacZ reporter is strongly expressed in cell bodies, thus facilitating the identification of individual cells. Consistent with our previous study (Franco et al., 2012) , the vast majority of cells fate mapped by Cux2-Cre expressed Satb2 (Figure 2A ) but not Ctip2 ( Figure 2B ) or Tle4 (not shown). We next extended our analyses to the Ai9 tdTomato reporter (Madisen et al., 2010) for better comparison with Guo et al. (2013) . We used Satb2 and Ctip2 as markers of corticocortical and corticofugal projection neurons, respectively ( Figures 2C and 2D ). There was strong overlap between Satb2 and tdTomato in upper and lower layers ( Figure 2D (Zimmer et al., 2004) . Consistent with this and with our earlier findings (Franco et al., 2012) , we found that 10% of all cells in the Cux2-Cre lineage expressed the interneuron marker Gad65/67 (Figures 2F-2I and S2F; 6% in upper layers and 17% in lower layers). Since Ctip2 is expressed in a subset of interneurons (Figures 2F-2I Figure 2H ). In upper layers, nearly all recombined Ctip2 + cells were interneurons ( Figure 2I ). Our Cux2-Cre data were in stark contrast to the patterns in Neurod6-Cre and Emx1-Cre, which drive recombination in all neocortical projection neurons but not interneurons (Belvindrah et al., 2007b; Gorski et al., 2002; Wu et al., 2005) . Ninety percent and eighty-eight percent of all Ctip2 + cells belonged to the Neurod6-Cre and Emx1-Cre lineages, respectively, whereas only 7% of all Ctip2 + cells belonged to the Cux2-Cre lineage (many of which are interneurons) ( Figure S2G ). Thus, unlike in fate-mappings with Neurod6-Cre and Emx1-Cre, very few cells in the Cux2 lineage are Ctip2 + /Satb2 À corticofugal projection neurons.
We reported that astrocytes were not detected in the Cux2-CreERT2 fate-mapped lineage at P10 (Franco et al., 2012) . If Cux2 + progenitors generate astrocytes at the end of upper-layer neurogenesis, P10 may be too early a time point to observe lateborn, morphologically mature astrocytes. We therefore analyzed later time points in Cux2-Cre;Ai9 animals using an antibody against the astrocyte marker Aldh1L1. Only a minor fraction of Aldh1L1 + astrocytes were within the Cux2-Cre fate-mapped lineage ( Figure S2H ). These data confirm our published findings (Franco et al., 2012) , which concluded that the vast majority of excitatory neurons in the Cux2-Cre lineage are Satb2 + projection neurons that are abundant in upper neocortical cell layers but can also be found in lower layers. In agreement with published findings (Franco et al., 2012; Zimmer et al., 2004) , Cux2-Cre also labels a subset of interneurons and a minor fraction of Ctip2 + projection neurons and neocortical astrocytes. In light of our discovery that expression of transgenes from the Cux2 locus is dependent on genetic background and breeding strategies, the discrepancy between our study (Franco et al., 2012) and that of the Chen laboratory (Guo et al., 2013) is likely explained by altered recombination patterns caused by differences in genetic background and breeding strategies used to maintain the Cux2-Cre and Cux2-CreERT2 lines.
Temporal Genetic Fate-Mapping Using Cux2-CreERT2
Mice Identifies a Population of Fate-Restricted RGCs Like other mice that constitutively express Cre, Cux2-Cre mice do not inform about the time point when recombination occurs. Inducible genetic fate-mapping using CreERT2 allows for temporal control over recombination by activating recombination with tamoxifen at defined time points to investigate progenitor-offspring relationships (Hayashi and McMahon, 2002; Zervas et al., 2004) . We showed previously that an early E10.5 injection of tamoxifen into Cux2-CreERT2;Ai9 mice labeled RGCs that gave rise to neurons in the P10 neocortex that predominantly resided in upper neocortical layers (Franco et al., 2012) . To extend these findings, we injected the faster-acting and shorter-lived tamoxifen metabolite 4-hydroxy-tamoxifen (4-OHT) (Guenthner et al., 2013) into Cux2-CreERT2;Ai9 animals at E10.5 and E11. (E) Neocortex from Cux2-CreERT2;Ai9 animals injected with 4-OHT at E10.5 and analyzed at P65 for Satb2 (green) and Ctip2 (blue) expression in recombined tdTomato + cells (red).
(legend continued on next page)
largely absent from the emerging neocortex ( Figure 3A) . As shown for tamoxifen induction (Franco et al., 2012) , a subpopulation of Pax6 + RGCs in the VZ expressed tdTomato one day after injection of 4-OHT ( Figure 3B ), confirming recombination in progenitors. CreERT2 was active in the 4-OHT-injected animals for only a short time period. Two days after 4-OHT injection into Cux2-CreERT2 pregnant dams, we used in utero electroporation to introduce a Cre-responsive EGFP-expression plasmid into the VZ of the embryos. When we analyzed the brains two days later, we did not observe reporter activation (Figures S3A-S3C ). In controls, the same Cre-responsive EGFP-expression plasmid was activated in the presence of constitutively active Cre (data not shown; Franco et al., 2012) . Thus, in experiments with Cux2-CreERT2 mice recombination was induced in progenitors within one day of 4-OHT administration but not in differentiated neurons that emerge several days later. We next analyzed the distribution and molecular identities of fate-mapped cells in mature brains at P20 and P65. A large fraction of cells derived from the Cux2-CreERT2 + progenitor lineage were located in upper layers, with a smaller number of recombined cells settling in lower layers ( Figures 3C-3F ). The distribution of cells in upper and lower layers ( Figure 3G ) was similar to the distribution of cells cumulatively fate-mapped with Cux2-Cre (Franco et al., 2012) . The identities of the cells in the Cux2-CreERT2 lineage were determined using molecular markers to quantify 1,745 cells in serial sections from nine animals ( Figures  3D-3F and 3H ). Even among cells positioned in lower layers, nearly all recombined cells were Satb2 + ( Figure 3H ; > 80% for E10.5 injections analyzed at P65; > 90% for E11.5 injections analyzed at P20). Some recombined cells expressed Ctip2, but most of these co-expressed Satb2 ( Figure 3H ). Only 2%-3% of recombined cells were Ctip2 + and Satb2 À . In agreement with cumulative fate-mapping results, some of the recombined cells in lower layers were interneurons ( Figures S3D-S3H ). Consistent with earlier findings (Franco et al., 2012) , we rarely found astrocytes in the Cux2-CreERT2 lineage in P10 brains following 4-OHT injections at E10.5 ( Figure S2I ). Recombined astrocytes were detected at P20 (Figure 3C , arrows) and more frequently at P65 ( Figure S2I ). This is consistent with the late postnatal local proliferation of astrocytes in the neocortex (Ge et al., 2012) and suggests that the small pool of astrocytes in the Cux2-CreERT2 fate-mapped lineage is amplified postnatally by proliferation.
In summary, our temporal genetic fate-mapping results provide evidence that neocortical progenitors of the Cux2-CreERT2 lineage that are labeled around E10.5-E11.5 generate predominantly Satb2 + projection neurons, as well as interneurons and a minor population of astrocytes.
DISCUSSION
The study by Guo et al. (2013) has raised concerns regarding the fate-restriction of Cux2-Cre + progenitors. Although the interpretation of their data was confounded by the fact that they analyzed cell lineage in the immature cortex, a further likely explanation for this discrepancy is that the Chen laboratory used Cux2-Cre/CreERT2 mice that no longer expressed Cre in a pattern reflecting that of the endogenous Cux2 locus, as a result of breeding strategies and genetic background variations that likely can cause epigenetic changes at the genetically modified Cux2 locus. The mice used by the Chen laboratory were derived from colonies in our laboratory that had been maintained by homozygous sibling matings for over ten generations (the mice were first shipped to Stanford from where they were imported to the Chen laboratory), a breeding scheme that we now show affects the expression pattern of the Cre transgenes. Once established, the shifted recombination patterns ( Figures  1B and 1D ) were maintained even in mice that were bred to C57BL/6J wild-type mice to obtain mice heterozygous for the transgenic locus, indicating that the epigenetic changes are stably inherited on the C57BL/6J background (but not following outbreeding to ICR mice). The shifted expression patterns exhibited equal distributions between upper and lower layers that closely resembled the distribution reported by Guo et al. (2013) . Additionally, in their Matters Arising Response article (Eckler et al., 2015) the Chen laboratory achieved a very sparse ''clone''-like recombination pattern in Cux2-CreERT2 mice by injecting 4 mg tamoxifen per 40 g body weight, which is twice the amount that we used to induce robust widespread recombination throughout upper neocortical cell layers (Franco et al., 2012) . Together these data suggest that the Chen laboratory is working with Cux2-Cre/CreERT2 mice with shifted recombination patterns. Notably, at the time of shipment we were not aware of the effects of breeding scheme and genetic background on transgene expression from the Cux2 locus. By analyzing mice that exhibited reproducible recombination patterns recapitulating the expression pattern of the endogenous Cux2 gene as determined by in situ hybridization, we provide further evidence that the VZ of the neocortex contains a subpopulation of RGCs that is fate restricted. Only a subset of RGCs express the Cux2 gene and cumulative genetic fatemapping experiments using Cux2-Cre mice demonstrate that the vast majority of the lineage-traced cells in the adult neocortex are Satb2 + corticocortical projection neurons that are abundant in upper neocortical layers but can also be found in lower layers (Alcamo et al., 2008; Britanova et al., 2008) . Using temporal genetic fate-mapping, we demonstrate that cells derived from Cux2-CreERT2 + VZ progenitors generate predominantly Satb2 + projection neurons, whereas the vast majority of Ctip2 + neurons is derived from progenitors that do not belong to the Cux2 + RGC lineage. Notably, although we used an unbiased approach to quantify cells in serial sections along the rostrocaudal axis from sparsely labeled brains, we cannot claim that we analyzed true clones derived from single progenitors. In this regard, we are concerned about the claim by Eckler et al. (2015) that they carried out a clonal analysis. Cell clones in their (F) Higher-magnification view of the neocortex from Cux2-CreERT2;Ai9 animals analyzed as in (E).
(G and H) Quantification of the layer distribution (G) and molecular marker expression (H) in isolated recombined ''clones'' in serial sections from injections at E10.5 and E11.5, analyzed at P65 and P20, respectively (mean ± SEM); 1,745 cells from nine animals were analyzed in ''clones'' that spanned several cell layers in serial sections. Scale bars: (B), left to right: 100, 100 and 50 mm; (C) and (E), 100 mm; (D), 100 mm; 25 mm for boxed insets; (F), 50 mm.
study spanned more than 0.5 mm along the rostrocaudal axis and the authors analyzed thousands of cells for each brain. This cell spread and density appears far too high to represent clones. This is a particularly important point for additional lineage-tracing studies carried out by Guo et al. (2013) and Eckler et al. (2015) using FezF2-CreERT2 mice. The authors observed that in these mice cells in upper and lower layers were lineage traced. However, it is unclear from their analysis whether the cells in upper or lower layers were derived from single progenitors. Guo et al. (2013) concluded that most cells in the Cux2-Cre lineage in the VZ are interneurons and that Cux2-Cre is not expressed in progenitors because they could not detect Cux2 protein in the VZ. However, we show that Cux2-Cre and Cux2-CreERT2 induce recombination in a subset of Pax6 + RGCs and that Cre protein is present in VZ progenitors. These data are consistent with in situ hybridization studies for Cux2 that revealed expression of Cux2 mRNA in RGCs and IPs in the VZ and SVZ (Franco et al., 2012; Nieto et al., 2004; Zimmer et al., 2004) . Translation of the Cux2 mRNA may be initiated later, as reported for other genes in the VZ/SVZ (Yang et al., 2014) , or available antibodies may not be sensitive enough for detecting Cux2. Significantly, the number of proliferating IPs in the neocortex is increased in mice lacking Cux2, suggesting that Cux2 protein is expressed in progenitors and acts to restrain their proliferation (Cubelos et al., 2008) . In this regard, we are surprised that interneurons appear absent in the lineage analysis carried out by Eckler et al. (2015) , since they reported in their previous study (Guo et al., 2013 ) that interneurons are abundantly recombined with Cux2-CreERT2 mice. Perhaps Cre was no longer expressed in interneurons in the mice used in the recent study (Eckler et al., 2015) due to changes in gene expression caused by breeding strategies. We also show that the vast majority of neocortical neurons in the Cux2-Cre lineage of adult mice are Satb2 + corticocortical projection neurons, some are interneurons, and only a very minor percentage are Ctip2 + /Satb2 À projection neurons. These data provide important insights into the total cell population that expresses Cre from the Cux2 locus at any time during their development and provide evidence for restriction within the Cux2-Cre fate-mapped lineage. Notably, additional support for expression of Cux2 in a restricted subset of progenitors comes from functional studies. The Dab1 gene regulates migration of projection neurons of all neocortical cell layers from the VZ into the cortical wall. When Dab1 is inactivated with Cux2-Cre, migration of upper-layer neurons is disrupted, while deep-layer neurons are largely unaffected (Franco et al., 2011) . Our temporal genetic fate-mapping studies indicate that Cux2-CreERT2 + progenitors in the neocortical VZ at E10.5-11.5 generate a restricted subset of neocortical projection neurons. Although we observed some variations in the number of fate-mapped projection neurons in upper layers ranging from 75% to 89%, which differed between functional cortical areas, the vast majority of neurons in the Cux2-CreERT2 lineage in all cases expressed Satb2, a marker for corticocortical projection neurons (Fame et al., 2011; Molyneaux et al., 2009; Sohur et al., 2014) . Variations in layer distribution may depend on functional domains of the neocortex and differences in experimental protocol (e.g., kinetics of tamoxifen versus 4-OHT) but do not change the conclusion that Cux2-CreERT2 + progenitors are restricted in their fate potential.
A study using mosaic analysis with double markers (MADM) concluded that single RGCs in the Emx1-CreERT2 lineage produced clones containing neurons with upper-and lower-layer identities (Gao et al., 2014) . Notably, MADM depends on Cremediated interchromosomal mitotic recombination during the G2 phase of the cell cycle (Gao et al., 2014) . Recombination efficiency will depend on cell-cycle length and on the genetic locus of the MADM reporter and thus likely does not capture all progenitor types with equal probability. Perhaps Emx1-CreERT2 and MADM preferentially label a slowly proliferating multipotent progenitor subtype that subsequently generates various lineagerestricted progenitors with faster proliferation kinetics, including those labeled by Cux2-CreERT2. Surprisingly, Gao et al. (2014) concluded that during an asymmetric neurogenic division, a single RGC produces eight or nine neurons. This result is difficult to reconcile with studies using Tbr2-Cre to lineage-trace the output of IP cells (Vasistha et al., 2014) . IPs are generated from RGCs and proliferate before generating neurons (Miyata et al., 2004; Noctor et al., 2004) . Vasistha et al. (2014) concluded that IPs predominantly generate clones comprising > 16 cells. The observation that single Emx1-CreERT2 + RGCs produce clones that are smaller than those traced by their IP offspring is difficult to explain but may reflect preferential labeling of a specific RGC sub-lineage with MADM.
In summary, we conclude that the neocortical VZ contains lineage-restricted progenitors around E10.5-11.5 that can be traced with Cux2-CreERT2 mice. We further conclude that Cux2-Cre mice are a useful tool to trace the entire Cux2-lineage. It is critical when using these tools to control for genetic background, while also avoiding breeding schemes that allow for germline recombination.
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